| View |
|
BR-824
|
Lutropin Alfa
|
Luveris
|
75 IU (equivalent to 3.7 mcg/mL)
|
Lyophilized Powder For Injection (SC)
|
Prescription Drug (RX)
|
2 mL Type I Glass Vial + 2 mL Vial containing 1 mL Water for Injection (Diluent) (Box of 1's)
|
-
|
Merck Serono SA
|
Switzerland
|
|
Merck, Inc.
|
Merck, Inc.
|
-
|
30 March 2021
|
13 July 2026
|
| View |
|
BR-825
|
Epoetin Alfa
|
Renogen
|
2000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Clear Glass Vial (Box of 1's) (Single use)
|
-
|
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
|
China
|
|
UNILAB, Inc.
|
|
Renewal
|
30 March 2021
|
18 April 2026
|
| View |
|
BR-826
|
Diphtheria, Tetanus, Pertussis (Whole-Cell), Recombinant Hepatitis B, Haemophilus Influenzae Type B Combined Vaccine
|
Easyfive TT
|
[see reverse for formulation]
|
Suspension for Injection (IM)
|
Prescription Drug (Rx)
|
Glass Vial x 0.5mL (single dose)
|
Vaccine
|
Panacea Biotec Limited (Vaccine Division)
|
India
|
|
Vizcarra Pharmaceutical Inc.
|
Vizcarra Pharmaceutical Inc.
|
Automatic Renewal
|
07 August 2021
|
04 August 2026
|
| View |
|
BR-827
|
Typhoid Polysaccharide Vaccine
|
Typbar
|
25 mcg/0.5 mL
|
Solution for Injection (IM)
|
Prescription Drug (RX)
|
Type I pre-filled glass syringe x 0.5 mL (Box of 1's).
Single dose.
|
-
|
Bharat Biotech International Ltd.
|
India
|
N/A
|
ULIVaccines, Inc.
|
GB Distributors Inc.
|
-
|
18 March 2022
|
15 August 2026
|
| View |
|
BR-828
|
Typhoid Polysaccharide Vaccine
|
Typbar
|
Formulation: Each dose (0.5 mL) contains: Purified Vi-capsular polysaccharide of Salmonella typhi (Ty2 strain) ................25 mcg
|
Solution for Injection (IM)
|
Prescription Drug (RX)
|
.5 mL in 2 mL Type I glass vial (Box of 1's). Single dose.
|
-
|
Bharat Biotech International Ltd.
|
India
|
N/A
|
ULIVaccines, Inc.
|
GB Distributors Inc.
|
-
|
18 March 2022
|
15 August 2026
|
| View |
|
BR-829
|
Follitropin Alfa
|
Gonal-F
|
450 IU/0.75 mL (33mcg/0.75mL)
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
0.75 mL Pre-filled Pen + 12 separate Needles 296 x 1/2" (Box of 1's)
|
Recombinant Follicle Stimulating Hormone
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
Renewal
|
30 March 2021
|
26 August 2026
|
| View |
|
BR-830
|
Gonal-F
|
Follitropin Alfa
|
300 IU/0.5 mL (22 mcg/0.5 mL)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
0.5 mL Pre-filled Pen + 8 Separate Needles 296 x 12"
(Box of 1’s)
|
-
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
-
|
17 May 2021
|
26 August 2026
|
| View |
|
BR-831
|
Follitropin Alfa
|
Gonal-F
|
900 IU/1.5 mL (66 mcg/1.5 mL)
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
1.5 mL Pre-filled Pen + 20 separate Needles 296 x 12”. (Box of 1’s)
|
-
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
-
|
29 June 2021
|
05 September 2026
|
| View |
|
BR-838
|
Denosumab
|
Prolia
|
60 mg/ mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
1 mL Type 1 prefilled glass syringe with a bromobutyl plunger-stopper and a staked-in needle with an elastomeric needle shield enclosed in a plastic rigid cover (Box of 1's)
|
-
|
Amgen Manufacturing Limited
|
United States of America
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial
|
05 October 2020
|
22 December 2024
|
| View |
|
BR-839
|
Measles and Rubella Vaccine (Live)
|
SII MR VAC
|
NLT 1000 CCID50/0.5 mL
|
Lyophilized Powder For Injection (S.C.)
|
Prescription Drug (RX)
|
0.5 mL amber Type I glass vial with lyophilized powder
+ 0.5 mL Sterile Water for Injection (diluent) (Box of 50's). Single dose.
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
N/A
|
Medical Vaccines Online Deliveries
|
Medical Vaccines Online Deliveries
|
Initial (Variation)
|
05 December 2022
|
05 December 2027
|
| View |
|
BR-846
|
Interferon-Beta 1B
|
Betaferon
|
250mcg (8million/ IU/mL)
|
Lyophilized powder for injection (SC)
|
Prescription Drug (Rx)
|
1 Type I glass vial containing 0.3mg Lyophilized powder + 1.2mL diluent in2.25mL pre-filed syringe (Box of 15's)
|
Immunostimulant
|
Bayer Pharma AG
|
Germany
|
|
Bayer Philippines, Inc.
|
|
Renewal
|
07 March 2022
|
15 February 2027
|
| View |
|
BR-851
|
Bacillus Calmette-Guerin Vaccine (Live, Attenuated)
|
SII-Onco-BCG
|
40 mg/mL
|
Lyophilized Powder for Intravesical Instillation
|
Prescription Drug (RX)
|
Single dose. 4 mL Type I amber glass vial (Box of 3
monocartons in a carton)
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
|
SMHP Marketing & Consultancy
|
SMHP Marketing & Consultancy
|
Initial [Variation]
|
18 December 2023
|
18 December 2028
|
| View |
|
BR-853
|
Denosumab
|
Xgeva
|
70 mg per mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
1.7 mL in 3 mL Type I glass vial with a butyl rubber stopper and an aluminum seal with a plastic flip-off dust cover (Box of 1's)
|
-
|
Amgen Manufacturing Limited
|
U.S.A
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial
|
30 August 2023
|
30 August 2028
|
| View |
|
BR-856
|
Enoxaparin Sodium
|
Olxarin
|
2,000 IU/0.2 mL (20mg/0.2 mL)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
0.2 mL Borosilicate Glass Pre-filled Syringe with Rubber Stopper and Plunger Rod (Box of 2's)
|
-
|
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
|
China
|
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Initial
|
04 August 2021
|
04 April 2025
|
| View |
|
BR-857
|
Enoxaparin Sodium
|
Olxarin
|
8,000 IU/0.8mL (80mg/0.8mL)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
0.8 mL Borosilicate Glass Pre-filled Syringe with Rubber Stopper and Plunger Rod (Box of 2's)
|
-
|
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
|
China
|
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Initial
|
04 August 2021
|
04 April 2025
|
| View |
|
BR-858
|
Enoxaparin Sodium
|
Olxarin
|
6,000 IU/0.6mL (60 mg/0.6mL)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
0.6 mL Borosilicate Glass Pre-filled Syringe with Rubber Stopper and Plunger Rod (Box of 2's)
|
-
|
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
|
China
|
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Initial
|
04 August 2021
|
04 April 2025
|
| View |
|
BR-859
|
Recombinant Human Erythropoietin Alfa
|
Eposis
|
2000 I.U./0.5mL
|
Solution For Injection (I.V./S.C.)
|
Prescription Drug (RX)
|
0.5mL pre-filled Type I glass syringe with needle in individually sealed plasctic tray per box of 6's
|
Hematopoietic Growth Factor
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
|
New Marketlink Pharmaceutical Corporation
|
New Marketlink Pharmaceutical Corporation
|
Renewal
|
21 April 2022
|
16 April 2027
|
| View |
|
BR-860
|
Enoxaparin Sodium
|
Olxarin
|
4,000 IU/0.4mL (40 mg/0.4 mL)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
0.4 mL Pre-filled glass syringe with Rubber Stopper and Plunger Rod (Box of 2's)
|
-
|
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
|
China
|
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Initial
|
04 August 2021
|
17 April 2025
|
| View |
|
BR-868
|
Recombinant Human Erythropoietin Alfa
|
Eposis
|
10,000 I.U./mL
|
Solution For Injection (I.V./S.C.)
|
Prescription Drug (RX)
|
1mL pre-filled Type I glass syringe with needle in individually sealed plastic tray
|
Hematopoietic Growth Factor
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
|
New Marketlink Pharmaceutical Corporation
|
New Marketlink Pharmaceutical Corporation
|
Automatic Renewal
|
01 April 2022
|
17 May 2027
|
| View |
BR-862_PI_01.pdf
|
BR-862
|
Belimumab
|
Benlysta
|
120 mg vial Each vial contains a sufficient amount of belimumab to deliver 120 mg in 1.5 mL when reconstituted as recommended with sterile Water for Injections. After reconstitution, each mL of solution contains 80 mg belimumab.
400 mg vial Each vial contains a sufficient amount of belimumab to deliver 400 mg in 5.0 mL when reconstituted as recommended with sterile Water for Injections. After reconstitution, each mL of solution contains 80 mg belimumab.
|
Powder for Solution for Injection (IV Infusion)
|
Prescription Drug (Rx)
|
Single dose. 5 mL (120 mg/vial) USP Type I glass
vial with chlorobutyl rubber stopper, sealed with aluminum crimp and flip-off cap (Box of l’s)
Single dose. 20 mL (400 mg/vial) USP Type I glass vial with chlorobutyl rubber stopper, sealed with aluminum crimp and flip-off cap (Box of 1’s)
|
-
|
GlaxoSmithKline Manufacturing S.P.A.
|
Italy
|
|
GlaxoSmithKline Philippines Inc.
|
GlaxoSmithKline Philippines Inc.
|
Initial
|
12 October 2021
|
17 April 2025
|